Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Dec 2013

Cheng Hong-Bin, Yue Wu, Xie Chen, Zhang Ru-You, Hu Shao-Shan, Wang Zhi

Abstract excerpt

Previous studies proposed that isocitrate dehydrogenase 1 (IDH1) mutation was associated with improved survival in patients with glioblastoma, but those studies reported varying estimates and yielded inconclusive results. The purpose of the present study was to determine the effect of IDH1 mutation on the prognosis of patients with glioblastoma by performing a meta-analysis. Pubmed and Embase databases were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Multivariate Analysis

Share to Mutation

Share to Prognosis

Share to Survival Analysis

Source

Identifiers

PMID: 23904262
DOI: 10.1007/s13277-013-0934-5

Genes

IDH1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IDH1 mutation is associated with improved overall survival in patients with glioblastoma: a meta-analysis.PMID 23904262Read ↗

Assessment of the Association between Isocitrate Dehydrogenase 1 Mutation and Mortality Risk of Glioblastoma Patients.Semantic proximity Read ↗

Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.Semantic proximity Read ↗

Prognostic role of IDH mutations in gliomas: a meta-analysis of 55 observational studies.Semantic proximity Read ↗

IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.Semantic proximity Read ↗

Prognostic significance of IDH 1 mutation in patients with glioblastoma multiforme.Semantic proximity Read ↗

Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.Semantic proximity Read ↗

Prognostic significance of IDH mutation in adult low-grade gliomas: a meta-analysis.Semantic proximity Read ↗

[Isocitrate dehydrogenase type I mutation as a prognostic factor in glioblastoma and a literature review].Semantic proximity Read ↗

Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 MutationSemantic proximity Read ↗

Isocitrate dehydrogenase 1: what it means to the neurosurgeon: a review.Semantic proximity Read ↗

Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients.Semantic proximity Read ↗

Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.